The role of CD4+CD25+T cells for immunological tolerance induction in organ transplantation
The role of CD4+CD25+T cells for immunological tolerance induction in organ transplantation
批准号:
16591248
负责人:
BECK Yoshifumi
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005
中文摘要
点击翻译按钮获取中文摘要
英文摘要
CD4+CD25+ regulatory T cells are selected in the thymus to control autoreactive thymic escapees preventing autoimmunity that can not be achieved by negative selection or deletion alone, thus playing an important role in the maintenance of immunological homeostasis. Not only significant in preventing autoimmunity, CD4+CD25+ regulatory T cells have also been shown to be involved in allograft tolerance in organ transplantation. Recent studies suggest that Foxp3, which encodes Scurfin, a member of the forkhead family of transcriptional regulators, is the key regulatory gene for the development of CD4+CD25+ regulatory T cells. We have formerly introduced two lines of HLA class I transgenic mice valuable to elucidate the role of HLA class I molecules in transplantation biology. Here, using a heterotopic cardiac transplantation model, we show that intrathymic inoculation of donor HLA class I derived synthetic peptide results in elevation of Foxp3 level in graft infiltrating lymphocytes and acceptance of the vascularized allograft. In addition, we demonstrate by adoptive transfer experiments that CD4+CD25+ regulatory T cells obtained following intrathymic inoculation of the synthetic peptide effectively induce graft specific tolerance without preconditioning of the recipient or use of additional immunosuppressive drugs. The study provides evidence suggestive of novel therapeutic option with CD4+CD25+ applicable to clinical transplantation.
期刊论文(20)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
A model of prediction system for adverse cardiovascular reactions by calcineurin inhibitors among patients with renal transplants using gene-based single-nucleotjde polymorphisms.
使用基于基因的单核苷酸多态性预测肾移植患者钙调神经磷酸酶抑制剂心血管不良反应的模型。
DOI:
--
发表时间:
2005
期刊:
J Hum Genet. 50(9)
影响因子:
--
作者:
[Y Kimura, et al., Mushiroda T]
通讯作者:
Mushiroda T
DOI:
10.1007/s10038-005-0275-3
发表时间:
2005-09-01
期刊:
JOURNAL OF HUMAN GENETICS
影响因子:
3.5
作者:
[Mushiroda, T, Saito, S, Ohnishi, Y]
通讯作者:
Ohnishi, Y
DOI:
10.1007/s11604-006-0044-z
发表时间:
2006-07-01
期刊:
Radiation medicine
影响因子:
--
作者:
[Maeda, Eriko, Uozumi, Kazuhito, Ohtomo, Kuni]
通讯作者:
Ohtomo, Kuni
Intrathymic Inoculation of Donor HLA Class-1 derived Peptide Generates Donor-Specific CD4+CD25+ regulatory T cells.
供体 HLA 1 类衍生肽的胸腺内接种可产生供体特异性 CD4 CD25 调节 T 细胞。
DOI:
--
发表时间:
期刊:
Transplantation Proc (In press)
影响因子:
--
作者:
[S.Tamura, Y.Beck, Y.Ando, H.Tahara]
通讯作者:
H.Tahara
A long-term survivor of metastatic acjnar cell carcinoma.
转移性腺泡细胞癌的长期幸存者。
DOI:
--
发表时间:
2007
期刊:
Pancreas 34(2)
影响因子:
--
作者:
[鎌田 正, 辻 比呂志, 永井 博彦, Hashimoto M]
通讯作者:
Hashimoto M
共 6 条
Analysis of tolerance induction using immunosuppresslve dendritic cells in transplantation
-
批准号:14370349
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.17万
-
财政年份:2002
-
负责人:BECK Yoshifumi
-
依托单位:
Evaluation of in vivo tolerogenicity of genetically modified recipient dendritic cells (syngeneic DC) pulsed with immunogenic peptides (allopeptides) derived from donor HLA molecule in HLA class I transgenic mouse.
-
批准号:12671142
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2000
-
负责人:BECK Yoshifumi
-
依托单位:
ANALYSIS OF ALLOANTIGENIC PEPTIDES
-
批准号:05807103
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.15万
-
财政年份:1993
-
负责人:BECK Yoshifumi
-
依托单位:
海外基金